ASPsiRNA information | siRNA Id: | aspsirna1825 |
siRNA Name: | W3/7 Fe775i | |
Mismatch information | Wild siRNA (As strand 3'->5'): | UUCGUCGUGUUACUACUCACG |
ASP-siRNA (As strand 3'->5'): | UUCGUCGUGUUACUGCUCGCG | |
Mismatch position in siRNA: | G3A,G7A | |
Gene Information | Gene Name | Flap structure-specific endonuclease 1 (Fen1) |
Target Sequence (5'->3'): | GCAGCACAAUGACGAGCGCAA | |
Wild allele (5'->3'): | AAGCAGCACAAUGAUGAGUGC | |
Mutant allele (5'->3'): | AAGCAGCACAAUGACGAGCGC | |
Position of siRNA on target gene: | 816-836 | |
Respective Gene/Protein Resources | GenBank Accession: | NM_004111.5 |
Cytogenic location: | 11q12.2 | |
Chromosomal coordinates: | 11:61,560,108-61,564,715 | |
UniProt ID: | P39748 | |
HUGO ID: | 3650 | |
Reference SNp(RefSNP): | NA | |
Disease/Mutation information | Target Mutation: | NA |
Matation type/variant: | NA | |
Mutation at gene level: | NA | |
Pathogenic status of mutation: | Mutation tolerance study | |
Disease: | Werner syndrome | |
Clinical Resources | ClinVar ID: | NA |
KEGG disease ID: | H00296 | |
OMIM ID: | 277700 | |
COSMIC: | Fen1 | |
DECIPHER: | Fen1 | |
GeneTests: | Fen1 | |
ASP siRNA details | Mutant allele (5'->3'): | AAGCAGCACAAUGACGAGCGC |
ASP-siRNA (As strand 3'->5'): | UUCGUCGUGUUACUGCUCGCG | |
Percentage efficacy of ASP-siRNA for mutant allele: | NA | |
Wild allele (5'->3'): | AAGCAGCACAAUGAUGAGUGC | |
ASP-siRNA (As strand 3'->5'): | UUCGUCGUGUUACUGCUCGCG | |
Percentage efficacy of ASP-siRNA for wild allele: | 22 | |
Relative difference: | NA | |
Wild siRNA details | Wild allele (5'->3'): | AAGCAGCACAAUGAUGAGUGC |
Wild siRNA (As strand 3'->5'): | UUCGUCGUGUUACUACUCACG | |
Percentage efficacy of wild siRNA for wild allele: | Moderately effective | |
Wild allele (5'->3'): | AAGCAGCACAAUGAUGAGUGC | |
ASP-siRNA (As strand 3'->5'): | UUCGUCGUGUUACUGCUCGCG | |
Percentage efficacy of Wild sirna for mutant allele: | Poor efficacy | |
Relative difference : | Moderate discrimination | |
General information | Mismatch incorporated in siRNA/Target: | siRNA |
Cell-line used: | HeLa | |
Experimental technique used: | Dual luciferase reporter assay | |
Transfection method: | Lipofectamine 2000 | |
siRNA expression method: | Ambion | |
Post-transfection duration: | 24 hours | |
Concentration used: | 1.44mg | |
Reference: | 16113241 | |
Delivery method: | Transfection | |
Article title: | Tolerated wobble mutations in siRNAs decrease specificity, but can enhance activity in vivo. | |
Authors: | Holen T, Moe SE, Sørbø JG, Meza TJ, Ottersen OP, Klungland A. | |
Journal Reference: | Nucleic Acids Res. 2005 Aug 19;33(15):4704-10. Print 2005. |
ASPsiRNA information | siRNA Id: | aspsirna1825 |
siRNA Name: | siCD46 | |
Mismatch information | Wild siRNA (As strand 3'->5'): | NA |
ASP-siRNA (As strand 3'->5'): | GAAUAACCUCUCUCGUGCU | |
Mismatch position in siRNA: | U:A pair | |
Gene Information | Gene Name | Complement regulatory protein (CD46) |
Target Sequence (5'->3'): | GCCCCCAATATGTGAAAAG | |
Wild allele (5'->3'): | NA | |
Mutant allele (5'->3'): | CUUAUUGGAGAGAGCACGA | |
Position of siRNA on target gene: | 779-797 | |
Respective Gene/Protein Resources | GenBank Accession: | NM_002389.4 |
Cytogenic location: | 1q32.2 | |
Chromosomal coordinates: | 1:207,925,382-207,968,860 | |
UniProt ID: | P15529 | |
HUGO ID: | 6953 | |
Reference SNp(RefSNP): | rs12190959 | |
Disease/Mutation information | Target Mutation: | c.104G>A, p.Cys35Tyr |
Matation type/variant: | single nucleotide variant/Missense variant | |
Mutation at gene level: | NG_009296.1:g.9964G>A | |
Pathogenic status of mutation: | Risk factor | |
Disease: | Hemolytic uremic syndrome | |
Clinical Resources | ClinVar ID: | 17049 |
KEGG disease ID: | H00106, H0027 | |
OMIM ID: | 120920 | |
COSMIC: | CD46 | |
DECIPHER: | CD46 | |
GeneTests: | CD46 | |
ASP siRNA details | Mutant allele (5'->3'): | CUUAUUGGAGAGAGCACGA |
ASP-siRNA (As strand 3'->5'): | GAAUAACCUCUCUCGUGCU | |
Percentage efficacy of ASP-siRNA for mutant allele: | 93 | |
Wild allele (5'->3'): | NA | |
ASP-siRNA (As strand 3'->5'): | GAAUAACCUCUCUCGUGCU | |
Percentage efficacy of ASP-siRNA for wild allele: | NA | |
Relative difference: | NA | |
Wild siRNA details | Wild allele (5'->3'): | NA |
Wild siRNA (As strand 3'->5'): | NA | |
Percentage efficacy of wild siRNA for wild allele: | NA | |
Wild allele (5'->3'): | NA | |
ASP-siRNA (As strand 3'->5'): | GAAUAACCUCUCUCGUGCU | |
Percentage efficacy of Wild sirna for mutant allele: | 93 | |
Relative difference : | NA | |
General information | Mismatch incorporated in siRNA/Target: | siRNA |
Cell-line used: | HEK293 | |
Experimental technique used: | Dual luciferase reporter assay | |
Transfection method: | Lipofectamine 2000 | |
siRNA expression method: | Dharmacon | |
Post-transfection duration: | 24 hours | |
Concentration used: | 13nM | |
Reference: | 15781493 | |
Delivery method: | Transfection | |
Article title: | A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. | |
Authors: | Du Q, Thonberg H, Wang J, Wahlestedt C, Liang Z. | |
Journal Reference: | Nucleic Acids Res. 2005 Mar 21;33(5):1671-7. Print 2005. Erratum in: Nucleic Acids Res. 2005;33(11):3698. |